Professional Activities:

Experience / Service

  • Academic AppointmentsTeaching Assistant, Department of Internal Medicine, Karolinska Institute Medical School, Dental Branch, Stockholm, Sweden, 1975−1980
  • Research Fellow, Department of Medical Radiobiology, Karolinska Institute Medical School and Section of Hematology, Department of Internal Medicine, Stockholm, Sweden, 1978−1981
  • Fellow, Developmental Therapeutics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 1981−1984
  • Assistant Professor of Medicine and Assistant Internist, Department of Hematology, Division of Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 1984−1988
  • Associate Professor of Medicine, Karolinska Institute Medical School, Stockholm, Sweden, 1987−present
  • Associate Internist and Assistant Professor of Medicine, Dept. of Hematology, Divi­sion of Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 1988−1991
  • Member of Staff, University of Texas Graduate School of Biomedical Sciences, Houston, TX, 1990−1994
  • Associate Professor of Medicine and Associate Internist, Dept. of Hematology, The University of Texas, MD Anderson Cancer Center, Houston, TX, 1991−1997
  • Professor of Pharmaceutical Science, University of Houston College of Pharmacy, Houston, TX, 1992−present
  • Professor of Medicine and Internist, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 1997−present

Administrative Appointments / Responsibilities

  • Associate Medical Director, Stem Cell Processing Laboratory, Dept. of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1990−present
  • Member of the Executive Committee of the Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003−2004
  • Chair Elect of the Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004−2005
  • Chair of the Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005−2006
  • Past Chairman, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006−2007
  • Vice Chairman, Conflict of Interest Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006−2007
  • Chairman, Conflict of Interest Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007−2009
  • Member of the Executive Committee of the Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007−2012
  • Chairman, Conflict of Interest Policy Review Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009−2010
  • Co-Chairman, Blue Ribbon Committee for Drafting and Implementing Policy and Bylaws for a Committee to Review and Manage, Institutional Conflict of Interest, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009−2011
  • Past Chairman, Conflict of Interest Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009−2011
  • Member, Search Committee for Vice President of Global Academic Affairs, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010−present
  • Associate Medical Director Cord Blood Bank, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010−present
  • Member, Global Academic Programs Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010−present
  • Member, Advisory Committee to The University of Texas Board of Regents, Search for New President, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011
  • Faculty Champion for the creation of a Sister-Institution relationship between The University of Texas MD Anderson Cancer Center and the Karolinska Institute Medical School, Stockholm, Sweden., The University of Texas MD Anderson Cancer Center, Houston, TX, 1/2011−12/2013
  • Chair, Institutional Bridge Funding Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/2011−present

Other Appointments/Responsibilities

  • Visiting Scientist, Ludwig Institute for Cancer Research, Stockholm Branch, Stockholm, Sweden, 1988−1989
  • Scientific Advisor, Orphan Medical Inc, Minnetonka, MI, 1995−1998
  • Scientific Advisor, Xechem Inc., New Brunswick, NJ, 1995−1998
  • Special Reviewer, Study Section for Orphan Products Development (OPD, Food and Drug Administration, Rockville, MD, 1996−present
  • Chief Scientific Officer, Sandra Technology, Inc, Houston, TX, 2001−2003
  • Member of the Board of Directors, Sandra Technology, Inc, Houston, TX, 2001−2003
  • Member of the Scientific Advisory Board, Sandra Technology, Inc., Houston, TX, 2001−2003

Endowed Positions

  • N/A

Consultantships

  • Aronex, Inc, The Woodlands, TX, Consultant, 1998−2001
  • Orphan Medical Inc, Minnetonka, MN, Consultant, 1998−2001
  • Orphan Medical Inc., Minnetonka, MN, Consultant, 2002−2003
  • Amgen, Inc, San Francisco, CA, Member, National Advisory Board, 2002−2003
  • ESP Pharma, Inc, Edison, New Jersey, Consultant, 2003−2005
  • ESP Pharma, Inc, Edison, Member, National Advisory Board, Advisory Board on Clinical Investigations using IV Busulfex, 2003−2006
  • PDL BioPharma, Inc., San Francisco, CA, Consultant, 2005−2007
  • Amgen, Thousand Oaks, CA, Chair, Palifermin Data Safety Monitoring Committee, 2006−2010
  • Saladax Inc., Bethlehem, PA, Member of Scientific Advisory Board, 2007−2010
  • Genzyme, Inc., Cambridge, Massachusetts, Clofarabine Slide Development Advisory Committee Member, 2008−2009
  • Otsuka Pharmaceuticals, Princeton, New Jersey, Consultant and Scientific Advisory Committee Member, 2008−2015
  • Kalo-Bios, Inc., San Francisco, CA, Consultant, 2009−2011
  • Hospital Israelita Albert Einstein, Sao Paulo, Brazil, Consultant, Consulting to establish a reference laboratory for clinical pharmacology with special emphasis on therapeutic dose monitoring of Busulfan in Hematopoietic stem cell transplantation for the state of Sao Paulo, Brazil., 2011−present

 Military or Other Governmental Service

  • Swedish Army, 1972
  • Swedish Army, 1974

Institutional Committee Activities

  • Medical Practice Committee, Member, 1986−1988
  • Institutional Review Board for Human Investigations, Member, 1990−1993
  • Biosafety Commit­tee, Vice Chairman, 1991−1993
  • Biosafety Committee, Member, 1993−1994
  • Clinical Ethics Committee, Member, 1993−1997
  • Biosafety Committee, Chairman, 1994−1995
  • Biosafety Committee, Member ex-officio, 1995−1996
  • Institutional Research Committee, Member, 1995−1998
  • Credentials Committee of the Medical Staff, Member, 1999−2002
  • Surveillance Committee (IRB), Member, 1999−2002
  • Transfusion Committee, Member, 1999−present
  • Faculty Senate, Member, 2000−2003
  • Clinical Ethics Committee, Adjuvant Clinical Ethicist, 2000−2005
  • University of Texas M.D. Anderson Search Committee for a New Director for the HLA Laboratory, Member, 2001
  • Clinical Ethics Committee, Member, 2001−2005
  • Research Funding Oversight Committee for the Institutional Research Grants Program, Member, 2001−present
  • Institutional Research Grants Program Oversight Committee, Member, 2001−present
  • University of Texas MD Anderson Review Committee for Clinical, Translational, and Population-based Projects under the Institutional Research Grants Program, Member, 2002−2003
  • MD Anderson Cancer Center's Presidential Blue Ribbon Committee, Member, 2002−2003
  • PDC/Pharmacology Users Oversight Committee, Member, 2002−2005
  • MD Anderson Conflict of Interest Committee, Member, 2002−2007
  • Institutional Review Board II, UTMDACC, Alternate Member, 2003−2004
  • Clinical Research Impact Committee, Member, 2003−2009
  • Institutional Research Grants Program Study Review Committee for Clinical, Translational and Population-Based Research Projects, Chairman, 2004−2005
  • University of Texas System Faculty Advisory Council to the Chancellor, Member, 2004−2007
  • Executive Committee of the Medical Staff, Member, 2004−2007
  • Faculty Compensation Committee, Member, 2005−2010
  • Institutional Bridge Funding Committee, Member, 2005−2011
  • Credentials Committee of the Medical Staff, Member, 2005−2011
  • Conflict of Interest Policy - Blue Ribbon Panel, Co-Chair, 2009−2012
  • Oversight Committee Global Academic Program, Member, 2010−present
  • International Advisory Board Charter, Member, 3/2014−present
  • Inpatient Operations Steering Committee, Member, 9/2014−present
  • Promotion and Tenure Committee, Member, 9/2014−present

Honors And Awards

  • Stipend, King Gustav VI Adolf's Jubilee Fund, Sweden, 1971
  • Special Fellow, Leukemia Society of America, 1984−1986
  • The Mohamed Ragab Prize and Silver Medal, Awarded at The First International Symposium of Tropical Medicine, Alexandria, Egypt, 1994
  • Dallas/Ft. Worth Living Legend Faculty Scholar Award for outstanding clinical research, UT MD Anderson Cancer Center, 2001
  • Aventis Oncology Drug Development Award, MDACC Division of Cancer Medicine, 2003−2004
  • Houston Intellectual Property Law Association’s Outstanding Inventor Award, 2009
  • Recipient of the 2009 Houston Mayor's Proclamation that September 10, 2009 Be Proclaimed Inventor's Day Because of Dr. Andersson Receiving the Houston Intellectual Property Law Association's Inventor Award, 2009
  • State of Texas Governor’s Commendation for Receiving the Outstanding Inventor Award from the Houston Intellectual Property Law Association, 2009
  • Admiral in the Texas Navy, Commissioned by Rick Perry, Governor, State of Texas, 2010
  • Chancellor's Entrepreneurship and Innovation Award, University of Texas System, 2010

Borje S. Andersson

Professor

 

  • : (713) 794-5743
    Fax No.: (713) 794-4902

  • DEPARTMENTDepartment of Stem Cell Transplantation
    The University of Texas, MD Anderson Cancer Center
  • COUNTRY USA